200780 — BCWorldPharm Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedMicro CapNeutral

Annual income statement for BCWorldPharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	R2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	62,079	72,703	75,111	74,814	75,800
Cost of Revenue
Gross Profit	20,098	27,403	31,963	28,045	30,586
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	63,613	70,905	68,746	73,314	73,803
Operating Profit	-1,534	1,797	6,365	1,500	1,997
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-2,936	-1,523	1,206	-2,766	-2,212
Provision for Income Taxes
Net Income After Taxes	-2,978	59.8	2,892	-3,316	-3,143
Minority Interest
Net Income Before Extraordinary Items
Net Income	-1,843	281	2,634	-4,433	-4,897
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-1,843	281	2,634	-4,433	-4,897
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-178	31.4	255	-435	-517
Dividends per Share